register

Medical and Science

$25M new funding for clinical trials

Health Industry Hub | August 24, 2020 |

Medical News: The Australian Government is providing $25 million for our best and brightest health and medical researchers to find breakthroughs in preventing and treating COVID-19.

Research is a key weapon in the fight against COVID-19 – and this funding will help to ensure that Australian researchers are on the frontline of the fight.

The Government will provide funding for new COVID-19-specific clinical trials involving high quality research into the virus. Funding for this research will be made available through the Government’s landmark Medical Research Future Fund (MRFF) under the Clinical Trials Activity initiative.

This initiative has a focus on addressing areas of health burden and unmet medical need – and, unequivocally, the COVID-19 pandemic represents an area of unmet medical need for all Australians.

It poses a significant and urgent threat to global health. It is a debilitating, life-threatening health condition, with, so far, no satisfactory options for prevention, diagnosis, early detection or treatment.

Providing funding for research into a disease such as COVID-19 is precisely why the Government established the MRFF. It allows for rapid funding of critical research to support and protect the Australian community.

These MRFF grants will fund crucial clinical trials to investigate effective mechanisms for the prevention and/or treatment of COVID-19 or its symptoms. Such mechanisms can then be translated into policy or practice.

Australia is contributing significantly to vaccine development work both in Australia and around the world, investing $333 million in vaccines, therapeutics and COVID medicines – including $256 million in vaccines.

The Government has also released Australia’s COVID-19 Vaccine and Treatment Strategy, guided by a group of medical and industry experts.

The Strategy sets out Australia’s approach to acquire doses of safe and effective COVID-19 vaccines based on:

1.         Research and development

2.         Purchase and manufacturing

3.         International partnerships

4.         Regulation and safety Immunisation administration and monitoring


News & Trends - MedTech & Diagnostics

Sussan Ley breaks ground as first female opposition leader amid Liberal party shake-up

Sussan Ley breaks ground as first female opposition leader amid Liberal party shake-up

Health Industry Hub | May 14, 2025 |

Sussan Ley has made history as the country’s first female opposition leader, edging out former shadow treasurer Angus Taylor in […]

More


News & Trends - MedTech & Diagnostics

New procedure shows durable impact in type 2 diabetes

New procedure shows durable impact in type 2 diabetes

Health Industry Hub | May 14, 2025 |

Medtech company, Endogenex, has unveiled promising data from an Australian clinical trial that could mark a turning point in type […]

More


News & Trends - Pharmaceuticals

AI rewrites the script on androgen deprivation therapy in prostate cancer

AI rewrites the script on androgen deprivation therapy in prostate cancer

Health Industry Hub | May 14, 2025 |

Artificial intelligence is showing promise in reshaping treatment decisions for men undergoing radiation therapy and androgen deprivation therapy (ADT) for […]

More


News & Trends - MedTech & Diagnostics

MSAC to assess CGM funding for expanded access in diabetes management

MSAC to assess CGM funding for expanded access in diabetes management

Health Industry Hub | May 14, 2025 |

Applications from Abbott Australasia and Australasian Medical & Scientific Limited (AMSL) for public funding of continuous glucose monitoring (CGM) devices […]

More


This content is copyright protected. Please subscribe to gain access.